QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • VistaGen Therapeutics, Inc. (VSTA) Featured In Seeking Alpha Article 0 comments
    Jan 24, 2013 6:05 PM | about stocks: VTGN

    A recent article published by Seeking Alpha, titled "Supreme Court Decision Is Bullish For Stem Cell Companies," reviews the recent high court decision that allows medical universities and science foundations to receive federal funding for embryonic stem cell research. Now supported by the federal government, the stem cell industry is anticipated to be a $6.6 billion market by 2016, more than 50% greater than its present size.

    To read the complete article, visit: seekingalpha.com/article/1120881

    Peter Harengel, author of the article, provided an overview of the progress taking place in the industry as companies continue to move forward with their stem cell research. VistaGen Therapeutics, for instance, recently announced a significant advance in its development of LiverSafe 3D™, a human liver cell-based bioassay system designed to predict liver toxicity and drug metabolism before animal or human testing. As with its CardioSafe 3D™ product, this bioassay system was designed to be used with modern medicinal chemistry to generate safer, proprietary chemical variants ("drug rescue variants") of once-promising drug candidates, as well as identify product failures earlier in the cost curve.

    Companies active in stem cell research are now much more attractive for a variety of factors. The election in Washington, D.C. has brought clarity to the health care sector, overall. The major players know what to expect and can now move forward. The recent Supreme Court decision will now focus the attention of many on stem cell research as more federal funding will enter the sector. Also of significance is that the political uncertainty is gone regarding stem cell research.

    2013 is poised to introduce a new flood of excitement in this up-and-coming health care market.

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: VTGN
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.